STEMCELLS, INC.

StemCells, Inc. to Present at Neurodegenerative Conditions Research and Development Conference

StemCells falls 3.4%

StemCells, Inc. Provides Additional Comments on Recent Awards From the California Institute for Regenerative Medicine

Biotech Industry Looks to Benefit From New Legislation Passed to Help Speed Up FDA Review Process

A tiny step forward for spinal cord injuries

StemCells awarded $20M from CIRM for Alzheimer's disease program

StemCells, Inc. Awarded $20 Million From the California Institute for Regenerative Medicine for Alzheimer's Disease Program

StemCells, Inc. CEO Discusses Interim 6-Month Data From Spinal Cord Injury Trial - Call Transcript

5 Speculative Biomedical Stocks Under $10: StemCells, Arena Pharmaceuticals, Dendreon, Complete Genomics, Idenix (NAS,NAS:STEM,ARNA)

StemCells rises 17.5%